Fennec Pharmaceuticals Inc.

FENC · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$21,926$18,705$22,675$26,634
Short-Term Investments$0$0$0$0
Receivables$19,324$17,502$15,448$12,884
Inventory$2,475$2,201$1,404$1,060
Other Curr. Assets$2,295$2,386$3,448$3,546
Total Curr. Assets$46,019$40,794$42,975$44,124
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$2,452$3,321$0$0
Tax Assets$0$0$0$0
Other NC Assets$742$761$3,428$822
Total NC Assets$3,194$4,082$3,428$822
Other Assets$0$0$0$0
Total Assets$49,213$44,876$46,403$44,946
Liabilities
Payables$5,860$5,941$5,280$3,241
Short-Term Debt$0$0$0$2
Tax Payable$0$0$0$0
Deferred Revenue$248$248$0$0
Other Curr. Liab.$3,697$2,225$3,091$3,676
Total Curr. Liab.$9,805$8,414$8,371$6,919
LT Debt$18,088$19,364$19,351$19,338
Deferred Rev, NC$24,537$24,561$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,270$0$24,561$24,561
Total NC Liab.$43,895$43,925$43,912$43,899
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$2
Total Liabilities$53,701$52,339$52,283$50,818
Equity
Pref Stock$0$0$0$0
Common Stock$147,508$146,165$145,979$145,608
Retained Earnings-$224,417-$223,998-$220,846-$219,681
AOCI$1,242$1,243$1,243$1,243
Other Equity$71,180$69,127$67,744$66,958
Total Equity-$4,488-$7,463-$5,880-$5,872
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$49,213$44,876$46,403$44,946
Net Debt-$3,837$659-$3,324-$7,294